Objective: The management of severe functional mitral regurgitation (FMR) in patients with heart failure (HF) and low ejection fraction is controversial, but percutaneous transcatheter procedures are promising. In this retrospective analysis, we aimed to assess the efficacy of the Carillon Mitral Contour System in patients with "inoperable" severe FMR. Methods: Seventy three patients (mean age 66.89, range 31-90 years) with congestive heart failure (CHF), severe FMR, and reduced ejection fraction (<35%) who underwent Carillon device implantation were examined. The study group consisted of patients with successfully implanted devices whereas the control group comprised patients in whom the device could not be deployed. The primary endpoint was combined allcause mortality and first hospitalization for HF (whichever came first). Results: The median (Q1, Q3) follow-up was 31 (11-49) months. The device was deployed successfully in 50 patients (implant group) and not in 23 patients (non-implant group). Both the primary endpoint and all-cause mortality were lower in the "implant" group, but the differences were not significant. The median to primary endpoint was 21 [95% confidence interval (CI) 8.8-33.2] and six (95% CI 0.1-11.9) months for the implant group and the non-implant group, respectively (p=0.078). Conclusion: Carillon Mitral Contour System implantation is a safe procedure and results in the reduction of all-cause mortality and combined endpoint of mortality and hospitalizations for HF in inoperable patients with severe FMR and low ejection fraction, although the difference did not meet the significance level.
Aim This study aimed to evaluate the relationship between endothelial activation and stress index (EASIX) score and 24-hour ambulatory blood pressure monitoring (24-h ABPM) parameters in patients with hypertension (HT). Methods This was a retrospective study. The EASIX score was calculated using the following formula [lactate dehydrogenase (LDH), U/L] × [creatinine (CRE), mg/dL] / [platelet (PLT), x109/L]. The EASIX variable was used for statistical analyses with Log2 (EASIX) transformation. Results The study included 192 patients aged between 18 and 70 years with a diagnosis of HT, with 40% (n = 77) of the patients being male. When the patients were grouped according to whether their blood pressure (BP) was within the target range, a statistically significant difference was found between the groups in terms of the EASIX score (p < 0.05). The threshold value for the EASIX score was found to be 0.48 because on receiver operating characteristic (ROC) analysis in the group with and without BP target because of 24-h ABPM. The area under the curve (AUC) and confidence interval (CI) values provided evidence of the usability of the threshold value [AUC = 0.755 (%95 CI = 0.685–0.825)]. Conclusion The EASIX score is a predictor that can be easily calculated in clinical practice using three blood parameters (LDH, CRE, and PLT). The EASIX score was found to have good predictive power in HT patients without comorbidities who were divided into groups of patients with and without target BP after 24-h ABPM.